Alternate day vs daily topical brinzolamide for the treatment of cystic maculopathy in inherited rod cone retinal degenerations
This study suggests both treatment regimens have similar functional outcomes, enabling a tailored and patient-centric approach to dosing.
Authors
- Andrea L. Vincent (ORCID: https://orcid.org/0000-0002-4185-3267)
- Orit Barrett (ORCID: https://orcid.org/0000-0001-5010-1035)
- Gülünay Kıray (ORCID: https://orcid.org/0000-0002-9618-9797)
- C. J. Barrett
Institutions
- Cedars-Sinai Medical Center (US)
- University of Auckland (NZ)
- White Clinic (PT)
- Greenlane Clinical Centre (NZ)
Publication Details
- Journal
- Ophthalmic Genetics
- Published
- 2026-03-31
- DOI
- https://doi.org/10.1080/13816810.2026.2651182
- Primary Topic
- Retinal Development and Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00